News

FUJIFILM Corporation announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative Executor: Wataru Akahata,…
Read More...

Lonza Bioscience has announced today the commercial release of the PyroCell MAT System, a sustainable and reliable solution for in vitro pyrogen testing. The new offering expands upon…
Read More...

Catalent announced the launch of its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms. The OneXpress solution…
Read More...

Alnylam Pharmaceuticals, Inc. announced positive topline results from the ILLUMINATE-B pediatric Phase 3 study of lumasiran, an investigational RNAi therapeutic targeting hydroxyacid…
Read More...

Covis Group S.à r.l. and AMAG Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash, or…
Read More...

ViralClear Pharmaceuticals, Inc. and Sorrento Therapeutics, Inc. announced the companies are exploring the synergistic potential of small molecules and antibodies combination therapies…
Read More...

Eisai Co., Ltd. and Seikagaku Corporation announced that the companies have entered into an agreement for the marketing alliance in South Korea for SI-613 (diclofenac conjugated sodium…
Read More...

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female oncology products in the precision medicine metastatic breast cancer…
Read More...

Kuur Therapeutics, a leader in the development of off-the-shelf CAR-NKT cell immunotherapies for the treatment of hematological and solid malignancies, today announced the treatment of…
Read More...

CStone Pharmaceuticals and Pfizer Investment Co. Ltd. and Pfizer Corporation Hong Kong Limited announced today the formation of a strategic collaboration that encompasses a $200 million…
Read More...

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Arbor Biotechnologies, an early-stage life sciences company,…
Read More...

Orgenesis Inc. and Koligo Therapeutics, Inc. announced that the two companies have entered into a definitive merger agreement, subject to final closing conditions, with expected…
Read More...

FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is pleased to announce it has entered into a manufacturing agreement with…
Read More...

AVROBIO, Inc. announced that the European Commission (EC) has granted orphan drug designation for AVR-RD-02, the company’s investigational gene therapy for the treatment of Gaucher…
Read More...

XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, announces an oversubscribed Series C funding of $318.8 million co-led by SoftBank Vision Fund…
Read More...

Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ (tofacitinib) for the treatment of children and adolescents 2 years and older…
Read More...

GlaxoSmithKline plc (GSK) announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and paediatric patients aged 12 years and…
Read More...

Gilead Sciences, Inc. and Eisai Co., Ltd. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted Gilead K.K. (Tokyo, Japan) regulatory approval of…
Read More...

AbCellera and IGM Biosciences, Inc. announced that they have entered into a multi-year, multi-target strategic research collaboration and license agreement to facilitate the discovery…
Read More...

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, and the US Army Medical Research and Development Command (USAMRDC),…
Read More...